Laboratorios Salvat S.A. and Arbor Pharmaceuticals, LLC Announce the Launch of Otovel (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) Otic Solution

BARCELONA, Spain and ATLANTA, Aug. 29, 2016 /PRNewswire/ -- Laboratorios Salvat S.A. (Salvat) and Arbor Pharmaceuticals, LLC (Arbor) jointly announce the launch of Otovel (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution, the...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news